Tofacitinib as monotherapy following methotrexate withdrawal in patients with psoriatic arthritis previously treated with open-label tofacitinib plus methotrexate: a randomised, placebo-controlled substudy of OPAL Balance
Titel:
Tofacitinib as monotherapy following methotrexate withdrawal in patients with psoriatic arthritis previously treated with open-label tofacitinib plus methotrexate: a randomised, placebo-controlled substudy of OPAL Balance
Auteur:
Nash, Peter Mease, Philip J Fleishaker, Dona Wu, Joseph Coates, Laura C Behrens, Frank Gladman, Dafna D Kivitz, Alan J Wei, James C Shirinsky, Ivan Menon, Sujatha Romero, Ana B Fallon, Lara Hsu, Ming-Ann Wang, Cunshan Kanik, Keith S